Advanced Cardiac Markers Testing in Fairfield County, CT
Although you hear less about it, cardiovascular disease continues to be the leading cause of death in the United States, with one American dying every 40 seconds from this disease. Nearly half of all heart attack victims had no prior risk indicating an oncoming heart attack.
Proactive health practitioners will want to identify the likelihood of their patients having cardiovascular disease, and one way to do so is through advanced cardiac markers testing. You will also hear this referenced as cardiac biomarkers testing. Less expensive than cardiac imaging and non-invasive, this is the initial testing strategy for an accurate cardiac condition diagnosis.
What Is Advanced Cardiac Markers Testing?
Advanced cardiac markers testing refers to the blood tests healthcare providers give to their patients whom they suspect of heart disease. Any time your heart is damaged or stressed, biomarkers are released into your blood. These biomarkers help your healthcare provider diagnose acute coronary syndrome (ACS) and cardiac ischemia. Both of these conditions mean your heart is receiving insufficient blood flow. The root causes of both are usually plaque buildup in your arterial walls, and hardening of the arteries (atherosclerosis).
There are six current advanced cardiac biomarker tests used to diagnose heart damage. They are as follows:
- Troponin: The most common test ordered, this chemical is elevated in the body within a few hours of heart damage, and remains elevated for up two weeks.
- High-sensitivity troponin: This version of the troponin test finds the same protein, but detects it at lower levels, making it able to discover accurate coronary syndrome (ACS) in patients with no symptoms. This test is not approved in the U.S., but is used in Europe, Canada and other countries.
- Creatine kinase (CK) and CK-MB: While the troponin test has mostly replaced this test, it is occasionally used to determine if a second heart attack has occurred after the first heart attack .
- Myoglobin: While used less frequently in the U.S. this test is sometimes used in conjunction with the troponin biomarker test to determine the likelihood of a future heart attack .
- hs-CRP: For those who have suffered a heart attack in the past, this test may be used to determine the likelihood of another heart attack .
- BNP (or NT-proBNP): This test indicates heart failure, and the increased risk of a future heart attack .
In addition, your healthcare provider may recommend a cholesterol test to determine your risk for cardiovascular disease (CVD). A cholesterol test will measure your total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol and triglycerides.
It is also common to receive advanced lipid testing. These tests can improve your healthcare provider’s assessment of your CVD risk in order to recommend more therapeutic and preventative strategies. They will measure lipoproteins such as very-low-density lipoprotein (VLDL), LDL particle number (LDL-P), HDL particle number (HDL-P) and particle size. In combination with advanced lipid testing, inflammation testing which looks at specific inflammation markers such as myeloperoxidase (MPO), high sensitivity c-reactive protein (hs-CRP) and lipoprotein-associated phospholipase A2 (LpPLA2), can help to better identify narrowing or blocked arteries due to plaque buildup.
Request more information about advanced cardiac markers testing today. Call (929) 244-4466 or contact Manhattan Integrative Medicine online.
Manhattan Integrative Medicine
Address308 5th Ave
New York, NY 10001
8:00 am - 5:00 pm
Tue: 8:00 am - 5:00 pm
Wed: 8:00 am - 5:00 pm
Thu: 8:00 am - 5:00 pm
Fri: 9:00 am - 5:00 pm